source
- Former Recursion CEO Chris Gibson joins Dimension Capital as operating partnerChris Gibson, who led Recursion Pharmaceuticals for a decade, has taken a new role at venture firm Dimension Capital. At Dimension, he will serve as an operating partner, bringing his experience a…
- NYU's Neil Vasan steps down as acting chair of FDA's oncology drug advisory committeeNeil Vasan, a professor at NYU, has announced he is stepping down from his role as acting chair of the FDA’s Oncologic Drugs Advisory Committee (ODAC). Vasan has participated in 22 ODAC meetings a…